Importance of extracellular loop one of the neuropeptide S receptor for biogenesis and function

Peptides

Volumn 31, Issue 1, 2010, Pages 130-138

  Clark, Stewart D ^a   Tran, Ha T ^a   Zeng, Joanne ^a   Reinscheid, Rainer K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biogenesis; Extracellular loop one; GPCR; Mutagenesis; Neuropeptide S; Pharmacological chaperone

Indexed keywords

ALANINE; CALCIUM ION; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BIOGENESIS; CALCIUM CELL LEVEL; CELL SURFACE; CONTROLLED STUDY; DNA POLYMORPHISM; EMBRYO; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OXAZOLIDINONES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, SECONDARY; PYRAZINES; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

RODENTIA;

EID: 72749103405     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.10.015     Document Type: Article

References (24)

1. Bernier V., Bichet D.G., and Bouvier M. Pharmacological chaperone action on G-protein-coupled receptors. Curr Opin Pharmacol 4 (2004) 528-533
2. Bernier V., Stocco R., Bogusky M.J., Joyce J.G., Parachoniak C., Grenier K., et al. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem 281 (2006) 24704-24712
3. Chardin P., and McCormick F. Brefeldin A: the advantage of being uncompetitive. Cell 97 (1999) 153-155
4. D'Souza-Schorey C., Li G., Colombo M.I., and Stahl P.D. A regulatory role for ARF6 in receptor-mediated endocytosis. Science 267 (1995) 1175-1178
5. Duvernay M.T., Filipeanu C.M., and Wu G. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal 17 (2005) 1457-1465
6. Gottlieb D.J., O'Connor G.T., and Wilk J.B. Genome-wide association of sleep and circadian phenotypes. BMC Med Genet 8 Suppl. 1 (2007) S9
7. Gu F., and Gruenberg J. ARF1 regulates pH-dependent COP functions in the early endocytic pathway. J Biol Chem 275 (2000) 8154-8160
8. Hawtin S.R., Simms J., Conner M., Lawson Z., Parslow R.A., Trim J., et al. Charged extracellular residues, conserved throughout a G-protein-coupled receptor family, are required for ligand binding, receptor activation, and cell-surface expression. J Biol Chem 281 (2006) 38478-38488
9. Klausner R.D., Donaldson J.G., and Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116 (1992) 1071-1080
10. Klco J.M., Nikiforovich G.V., and Baranski T.J. Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop. J Biol Chem 281 (2006) 12010-12019
11. Morello J.P., Salahpour A., Laperriere A., Bernier V., Arthus M.F., Lonergan M., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105 (2000) 887-895
12. Okamura N., Habay S.A., Zeng J., Chamberlin A.R., and Reinscheid R.K. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J Pharmacol Exp Ther 325 (2008) 893-901
13. Okamura N., Hashimoto K., Iyo M., Shimizu E., Dempfle A., Friedel S., et al. Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1444-1448
14. Petaja-Repo U.E., Hogue M., Bhalla S., Laperriere A., Morello J.P., and Bouvier M. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. Embo J 21 (2002) 1628-1637
15. Reinscheid R.K. Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ 46 (2008) 145-158
16. Reinscheid R.K. Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods. Peptides 28 (2007) 830-837
17. Reinscheid R.K., Xu Y.L., Okamura N., Zeng J., Chung S., Pai R., et al. Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther 315 (2005) 1338-1345
18. Roth A.L., Marzola E., Rizzi A., Arduin M., Trapella C., Corti C., et al. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J Biol Chem 281 (2006) 20809-20816
19. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 1 page following 696
20. Silvente-Poirot S., Escrieut C., and Wank S.A. Role of the extracellular domains of the cholecystokinin receptor in agonist binding. Mol Pharmacol 54 (1998) 364-371
21. Van Craenenbroeck K., Clark S.D., Cox M.J., Oak J.N., Liu F., and Van Tol H.H. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J Biol Chem 280 (2005) 19350-19357
22. Wheatley M., Simms J., Hawtin S.R., Wesley V.J., Wootten D., Conner M., et al. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors. Biochem Soc Trans 35 (2007) 717-720
23. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497
24. Zeghouf M., Guibert B., Zeeh J.C., and Cherfils J. Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans 33 (2005) 1265-1268